Insider · CIK 0001679967

Lamothe Jeffrey G.

Reports to the SEC for 1 company · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001679967

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-06	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+961 sh	—	—	961
2026-08-06	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−961 sh	—	—	0
2025-08-06	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director, President and CEO	AAward	+17.3K sh	—	—	17,300
2025-07-17	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+5 sh	—	—	6
2025-07-17	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−5 sh	—	—	12
2025-03-03	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+2 sh	—	—	36
2025-03-03	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−2 sh	—	—	0
2025-03-02	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+3 sh	—	—	34
2025-03-02	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−3 sh	—	—	4
2024-08-08	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+42 sh	—	—	894
2024-08-08	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+272 sh	—	—	1,166
2024-08-08	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−42 sh	—	—	41
2024-08-08	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−272 sh	—	—	0
2024-07-17	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director, President and CEO	AAward	+12.8K sh	—	—	12,825
2024-03-03	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+3,667 sh	—	—	37,504
2024-03-03	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−3,667 sh	—	—	3,667
2024-03-02	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+5,500 sh	—	—	33,837
2024-03-02	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−5,500 sh	—	—	11,000
2024-01-28	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+1,833 sh	—	—	28,337
2024-01-28	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−1,833 sh	—	—	0
2023-08-08	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+12K sh	—	—	24,671
2023-08-08	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+1,833 sh	—	—	26,504
2023-08-08	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−12K sh	—	—	11,979
2023-08-08	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−1,833 sh	—	—	3,667
2023-03-03	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+3,666 sh	—	—	12,692
2023-03-03	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−3,666 sh	—	—	7,334
2023-03-03	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director, President and CEO	AAward	+16.5K sh	—	—	16,500
2023-03-03	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+16.5K sh	—	—	16,500
2023-01-29	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+1,834 sh	—	—	9,026
2023-01-29	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−1,834 sh	—	—	1,833
2022-08-09	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director, President and CEO	AAward	+5,500 sh	—	—	5,500
2022-08-09	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+5,500 sh	—	—	5,500
2022-08-09	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director, President and CEO	AAward	+24K sh	—	—	23,958
2022-06-07	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director, President and CEO	AAward	+11K sh	—	—	11,000
2022-03-04	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+11K sh	—	—	11,000
2022-01-29	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+1,833 sh	—	—	7,192
2022-01-29	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+1,833 sh	—	—	3,667
2021-01-29	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+16.5K sh	—	—	16,500
2021-01-29	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director, President and CEO	AAward	+5,500 sh	—	—	5,500
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−2,695 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−1,928 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−3,128 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−2,407 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−2,407 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−4,814 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−4,814 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+7,380 sh	—	—	7,380
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+2,140 sh	—	—	2,140
2020-02-18	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+135K sh	—	—	134,800
2019-11-01	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+135K sh	—	—	135,384

Recent filings

Accepted (ET)
Aug 104
Lamothe Jeffrey G.0001193125-26-343079
SEC(opens sec.gov)
Aug 84
Lamothe Jeffrey G.0000950170-25-105930
SEC(opens sec.gov)
Jul 214
Lamothe Jeffrey G.0000950170-25-097267
SEC(opens sec.gov)
Mar 44
Lamothe Jeffrey G.0000950170-25-032197
SEC(opens sec.gov)
Aug 94
Lamothe Jeffrey G.0000950170-24-094816
SEC(opens sec.gov)
Jul 194
Lamothe Jeffrey G.0000950170-24-084952
SEC(opens sec.gov)
Mar 54
Lamothe Jeffrey G.0000950170-24-025915
SEC(opens sec.gov)
Jan 304
Lamothe Jeffrey G.0000950170-24-009003
SEC(opens sec.gov)

Companies

Aptevo Therapeutics Inc.Director, President and CEOAPVO

Address

2401 4TH AVENUE SUITE 1050

SEATTLE, WA, 98121